Late stent thrombosis and acute ST-elevation myocardial infarction in a case affected with COVID-19: A rare manifestation

IF 0.2 Q4 CARDIAC & CARDIOVASCULAR SYSTEMS

Research in Cardiovascular Medicine Pub Date : 2021-01-01 DOI:10.4103/rcm.rcm_39_20

R. Eskandarian, Z. Sani, M. Behjati, R. Alizadehsani, A. Shoeibi, Kourosh Kakhi, A. Khosravi, S. Nahavandi, S. S. Shariful Islam

{"title":"Late stent thrombosis and acute ST-elevation myocardial infarction in a case affected with COVID-19: A rare manifestation","authors":"R. Eskandarian, Z. Sani, M. Behjati, R. Alizadehsani, A. Shoeibi, Kourosh Kakhi, A. Khosravi, S. Nahavandi, S. S. Shariful Islam","doi":"10.4103/rcm.rcm_39_20","DOIUrl":null,"url":null,"abstract":"A 65-year-old male was introduced with a history of percutaneous coronary intervention 2 years ago who received Aspirin and Plavix. He was referred for coronary angiography after receiving thrombolytic therapy for ST-elevation myocardial infarction in precordial leads. On admission, he had dyspnea with low oxygen saturation, leukocytosis, lymphopenia, elevated C-reactive protein, and cardiac troponin levels. Transthoracic echocardiography demonstrated left ventricular ejection fraction (LVEF) of 25% and pulmonary artery pressure of 45 mmHg. A small thrombus at the site of the previously deployed stent was noticeable at coronary angiography. The chest computed tomography depicted significant involvement of the lungs manifested by peripheral ground-glass opacifications. A positive polymerase chain reaction confirmed coronavirus infection. He was oxygen dependent for 1 week. Gradually, his respiratory distress improved and his LVEF reached to 30% after discharge.","PeriodicalId":21031,"journal":{"name":"Research in Cardiovascular Medicine","volume":"10 1","pages":"20 - 22"},"PeriodicalIF":0.2000,"publicationDate":"2021-01-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":"1","resultStr":null,"platform":"Semanticscholar","paperid":null,"PeriodicalName":"Research in Cardiovascular Medicine","FirstCategoryId":"1085","ListUrlMain":"https://doi.org/10.4103/rcm.rcm_39_20","RegionNum":0,"RegionCategory":null,"ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"Q4","JCRName":"CARDIAC & CARDIOVASCULAR SYSTEMS","Score":null,"Total":0}

引用次数: 1

Abstract

A 65-year-old male was introduced with a history of percutaneous coronary intervention 2 years ago who received Aspirin and Plavix. He was referred for coronary angiography after receiving thrombolytic therapy for ST-elevation myocardial infarction in precordial leads. On admission, he had dyspnea with low oxygen saturation, leukocytosis, lymphopenia, elevated C-reactive protein, and cardiac troponin levels. Transthoracic echocardiography demonstrated left ventricular ejection fraction (LVEF) of 25% and pulmonary artery pressure of 45 mmHg. A small thrombus at the site of the previously deployed stent was noticeable at coronary angiography. The chest computed tomography depicted significant involvement of the lungs manifested by peripheral ground-glass opacifications. A positive polymerase chain reaction confirmed coronavirus infection. He was oxygen dependent for 1 week. Gradually, his respiratory distress improved and his LVEF reached to 30% after discharge.

查看原文本刊更多论文

一例新冠肺炎患者的晚期支架血栓形成和急性ST段抬高心肌梗死：罕见表现

一名65岁男性，2年前有经皮冠状动脉介入治疗史，接受阿司匹林和波立维治疗。在接受心前区ST段抬高型心肌梗死溶栓治疗后，他被转诊进行冠状动脉造影。入院时，他出现呼吸困难，伴有低氧饱和度、白细胞增多、淋巴细胞减少、C反应蛋白和心肌肌钙蛋白水平升高。经胸超声心动图显示左心室射血分数（LVEF）为25%，肺动脉压为45mmHg。冠状动脉造影显示，先前部署的支架部位有一个小血栓。胸部计算机断层扫描显示肺部明显受累，表现为周围磨玻璃样混浊。聚合酶链式反应阳性证实了冠状病毒感染。他有1周的时间依赖氧气。出院后呼吸窘迫症状逐渐好转，左心室射血分数达到30%。

本文章由计算机程序翻译，如有差异，请以英文原文为准。

求助全文

约1分钟内获得全文求助全文

来源期刊

Research in Cardiovascular Medicine CARDIAC & CARDIOVASCULAR SYSTEMS-

自引率

0.00%

发文量

审稿时长

17 weeks